CN101762701A - 一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 - Google Patents
一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 Download PDFInfo
- Publication number
- CN101762701A CN101762701A CN 200910087642 CN200910087642A CN101762701A CN 101762701 A CN101762701 A CN 101762701A CN 200910087642 CN200910087642 CN 200910087642 CN 200910087642 A CN200910087642 A CN 200910087642A CN 101762701 A CN101762701 A CN 101762701A
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- magnetic
- detection
- magnetic particle
- surface antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 37
- 238000001514 detection method Methods 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 27
- 239000000427 antigen Substances 0.000 title claims abstract description 25
- 102000036639 antigens Human genes 0.000 title claims abstract description 25
- 108091007433 antigens Proteins 0.000 title claims abstract description 25
- 239000006249 magnetic particle Substances 0.000 claims abstract description 42
- 229920003023 plastic Polymers 0.000 claims abstract description 11
- 238000012360 testing method Methods 0.000 claims description 46
- 239000002245 particle Substances 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 11
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 11
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 10
- 239000002274 desiccant Substances 0.000 claims description 9
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 8
- 239000000020 Nitrocellulose Substances 0.000 claims description 7
- 229920001220 nitrocellulos Polymers 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 230000005298 paramagnetic effect Effects 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- 238000007639 printing Methods 0.000 claims description 5
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000003365 glass fiber Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 239000008366 buffered solution Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 18
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 abstract description 8
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000011248 coating agent Substances 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 3
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 21
- 238000012856 packing Methods 0.000 description 11
- 238000004321 preservation Methods 0.000 description 11
- 238000013016 damping Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 239000011152 fibreglass Substances 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 4
- 239000004327 boric acid Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 230000005389 magnetism Effects 0.000 description 4
- 239000012982 microporous membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 241000337007 Oceania Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000003317 immunochromatography Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000012123 point-of-care testing Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000700739 Hepadnaviridae Species 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910087642 CN101762701A (zh) | 2009-06-24 | 2009-06-24 | 一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910087642 CN101762701A (zh) | 2009-06-24 | 2009-06-24 | 一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101762701A true CN101762701A (zh) | 2010-06-30 |
Family
ID=42493991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910087642 Pending CN101762701A (zh) | 2009-06-24 | 2009-06-24 | 一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101762701A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103063845A (zh) * | 2012-12-18 | 2013-04-24 | 苏州浩欧博生物医药有限公司 | 一种乙型肝炎病毒表面抗体的纳米磁微粒化学发光测定试剂盒及其制备方法和检测方法 |
CN103293295A (zh) * | 2013-05-07 | 2013-09-11 | 上海爱纳玛斯医药科技有限公司 | 检测hbv的磁性生物探针、试纸条及其制备和使用方法 |
CN103558399A (zh) * | 2013-11-06 | 2014-02-05 | 昆明云大生物技术有限公司 | 检测乙肝表面抗原的免疫层析试纸及其制备方法 |
WO2024245965A1 (en) * | 2023-05-26 | 2024-12-05 | Qbd (Qs-Ip) Limited | Antigen detection |
-
2009
- 2009-06-24 CN CN 200910087642 patent/CN101762701A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103063845A (zh) * | 2012-12-18 | 2013-04-24 | 苏州浩欧博生物医药有限公司 | 一种乙型肝炎病毒表面抗体的纳米磁微粒化学发光测定试剂盒及其制备方法和检测方法 |
CN103293295A (zh) * | 2013-05-07 | 2013-09-11 | 上海爱纳玛斯医药科技有限公司 | 检测hbv的磁性生物探针、试纸条及其制备和使用方法 |
CN103558399A (zh) * | 2013-11-06 | 2014-02-05 | 昆明云大生物技术有限公司 | 检测乙肝表面抗原的免疫层析试纸及其制备方法 |
WO2024245965A1 (en) * | 2023-05-26 | 2024-12-05 | Qbd (Qs-Ip) Limited | Antigen detection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105092861A (zh) | 一种crp/saa定量联合检测免疫荧光层析试纸及其制备方法 | |
CN101566631A (zh) | 一种联合检测hiv-1+2抗体和p24抗原的磁性免疫层析试纸条及其制备方法 | |
CN101140284A (zh) | 一种结核分枝杆菌抗体快速诊断试剂盒及其检测方法 | |
CN107976541A (zh) | 同步检测玉米赤霉烯酮和黄曲霉毒素b1的试纸卡、制备及检测方法 | |
CN101566636B (zh) | 一种定量检测血液中甲胎蛋白的磁性免疫层析试纸条的制备方法 | |
CN101762690A (zh) | 一种定量检测血液中c反应蛋白的磁性免疫层析试纸条及制备方法 | |
CN101762700A (zh) | 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法 | |
CN108535485A (zh) | 一种定量检测血液中ca153的时间分辨荧光免疫层析试纸条及制备方法 | |
CN101750498A (zh) | 一种检测乙肝e抗原的磁性免疫层析试纸条及其制备方法 | |
CN101236201A (zh) | 一种提高以胶体金属或乳胶颗粒作为标记物的检测试剂灵敏度的方法 | |
CN101762699A (zh) | 一种定量检测血液中肿瘤相关抗原125的磁性免疫层析试纸条及制备方法 | |
CN103901216A (zh) | 人h-fabp胶体金检测试纸及其制备方法 | |
CN101762697A (zh) | 一种定量检测血液中肿瘤相关抗原15-3的磁性免疫层析试纸条及制备方法 | |
CN110927395A (zh) | 一种检测甲基苯丙胺、吗啡和氯胺酮的三联试纸条及其制备方法和应用方法 | |
CN101762691A (zh) | 一种定量检测血液中PSA和fPSA的磁性免疫层析试纸条及制备方法 | |
CN204964521U (zh) | 一种crp/saa定量联合检测免疫荧光层析试纸 | |
CN101762701A (zh) | 一种检测乙肝表面抗原的磁性免疫层析试纸条及其制备方法 | |
Wang et al. | Development of an immunochromatographic test to detect white spot syndrome virus of shrimp | |
CN101750494A (zh) | 一种检测乙肝表面抗体的磁性免疫层析试纸条及其制备方法 | |
CN106248894A (zh) | 一种检测牛奶中抗生素残留的纸芯片 | |
CN108535495A (zh) | 一种定量检测血液中cyfra21-1的时间分辨荧光免疫层析试纸条及制备方法 | |
CN101750495A (zh) | 一种检测乙肝核心抗体的磁性免疫层析试纸条及其制备方法 | |
CN209264735U (zh) | 一种用于两步法免疫层析的高通量检测装置 | |
CN101762692A (zh) | 一种检测tb抗体的磁性免疫层析试纸条及其制备方法 | |
CN101738476B (zh) | 乙肝病毒前s1抗原快速诊断试剂盒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING KEMEI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: KEMEI DONGYA BIOLOGICAL TECHNOLOGY CO., LTD., BEIJING Effective date: 20111025 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20111025 Address after: 100094 Beijing city Haidian District Yongfeng base Feng Xian Road No. 7 North Park Applicant after: Beijing Kemei Biological Technology Co., Ltd. Address before: 100094 Beijing city Haidian District Yongfeng base Feng Xian Road No. 7 North Park Applicant before: Kemei Dongya Biological Technology Co., Ltd., Beijing |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100630 |